Better Benefits, Fewer Risks
Pharmaceutical Executive
Straddling the divide between drug discovery and drug delivery, Protarga doesn't fit neatly into any pharma category. It's not exactly a delivery technology company, because its products are patentable new entities that it plans to keep for itself. Nor is it purely biotech, because it works with chemical compounds. And in the end, president and CEO Nigel Webb expects Protarga to become a fully integrated pharma company-but only in the virtual sense.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
The 8 Market Access Performance Metrics You Should Be Tracking
March 25th 2025This guide offers an in-depth analysis of the essential KPIs that market access teams should track to measure success particularly across speed of access, breadth of access, and price performance. It includes real-life use cases and practical steps on how to get started.
